NCT04221126View on ClinicalTrials.gov

TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

August 8, 2019

Study Completion Date

December 9, 2019

Conditions
Normal Skin
Interventions
DEVICE

TMFI

Tixel rapidly transfer thermal energy by a metallic pyramid tip that enable skin contact through integrated pulsed movements. The rapid heating dehydrates he epidermis and superficial dermis and creates micropores with no coagulative damage of surronding tissue.

DRUG

ALA cream

ALA compounded in a cream

DRUG

ALA gel

ALA compounded in a gel

Trial Locations (1)

2400

Bispebjerg Hospital, Copenhagen

All Listed Sponsors
lead

Merete Haedersdal

OTHER

NCT04221126 - TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence | Biotech Hunter | Biotech Hunter